NICE
New OHE Consulting Report on Shaping Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
18 April 2016
OHE publishes new Consulting Report on shaping the research agenda to estimate relevant cost-effectiveness thresholds for Health Technology Assessment decision making.
Care at the End of Life: An Economic Perspective
6 April 2016
Just published is a book on the economics of end of life care, featuring a chapter by OHE’s Koonal Shah.
OHE Lunchtime Seminar on 19 April 2016: Evidence that challenges decision makers: experiences and examples
29 March 2016
Dr Amanda Adler, Chair of NICE Appraisal Committee B and Consultant Physician, will present an OHE Seminar on 19 April 2016.
An Analysis of NICE Technology Appraisal Decisions ‘Recommended in Line with Clinical Practice’
1 December 2016
This Research Paper explores decisions by the National Institute for Health and Care Excellence (NICE) that new technologies are to be recommended in line with clinical practice (RiLCP). The authors qualitatively assess documentation associated with RiLCP decisions to create a framework to describe common themes, and assess the level of patient access associated with each RiLCP decision.
Seminar at Glasgow Caledonian University: Local Health Care Expenditure Plans and Their Opportunity Costs
11 January 2016
OHE’s Sarah Karlsberg Schaffer presented at the Glasgow Health Economics Seminar Series the results of a paper on the value of the cost-effectiveness threshold in Scotland.
Uncertainty and Risk in HTA Decision Making
1 November 2016
The quality of decision-making in key public sector bodies dealing with resource allocation is a major determinant of their efficiency. One of the most difficult and contentious areas of decision-making is the way that uncertainty is dealt with.
A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications
1 May 2016
NICE’s decisions exert an influence on the allocation of fixed NHS budgets, but decisions for different types of health interventions (for example drugs and devices) are…
Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
4 January 2016
This report details the views of a selection of experts in the fields of health and welfare economics on the cost-effectiveness threshold used by the National…
Cost-per-QALY in the US and Britain
28 December 2015
Professor Weinstein compares the use of cost-per-QALY approaches in the UK and the US. Britain has got it closer to right, but may go a little…